543 results
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3G): one-year results of the BIOMAG-1 first-in-human study
25 May 2023
The 12-month outcomes of the BIOMAG-I first-in-human trial demonstrate a favorable safety profile for the third-generation magnesium scaffold and 38 % improved performance compared to its precursor.
Reviewer
Reviewer
EuroPCR 2023 Highlights: Coronary Interventions
20 May 2023 – From EuroPCR 2023
Nieves Gonzalo and Thomas Cuisset join Dejan Milasinovic in the PCR recording studio to share their takeaways from this rich edition of EuroPCR: intracoronary physiology guidance, post-PCI physiology, the increasing use of imaging to improve the clinical outcome of patients, new technologies such as drug-coated balloons,...
When to use drug coated balloons in de novo lesions?
What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.
Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...
Stent failure management - Contemporary management options - Part 2
18 May 2023 – From EuroPCR 2023
In this session, explore the evolving causes of restenosis in contemporary practice and understand how to tailor in-stent restenosis treatment based on its underlying mechanism. Discover why imaging is crucial for selecting the appropriate treatment in cases of in-stent restenosis, and learn that drug-coated balloons are...
DCB, DES, BRS - One fits all or all fit together?
18 May 2023 – From EuroPCR 2023
Check out this session to learn more about polymer-free treatment options with DCB and DES, increasing DCB in the daily cathlab routine, and the possibility of including BRS in the daily PCI routine.
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology
17 May 2023 – From EuroPCR 2023
If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...
Latest trends in PCI - Stentless PCI and the role of sustained limus release
17 May 2023 – From EuroPCR 2023
Explore the latest trends in percutaneous coronary intervention (PCI) in this session, focusing on stentless PCI and the role of sustained limus release technology. Join the discussion on how sustained limus release can expand the indications for drug-eluting balloons (DEB) and minimize the use of metal...
The next generation DES technology: innovative DES+DCB stent platform
Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.
Stent failure management - The optimal use of intracoronary imaging - Part 1
17 May 2023 – From EuroPCR 2023
Watch this session to discover the optimal use of intracoronary imaging, to learn more about the differential role of IVUS and OCT imaging in stent failure, to study a case of in-stent restenosis due to calcified neoatherosclerosis, and to learn about the available evidence for the...
